Although additional germline genetic testing was not done in patient SLS23, the CRC harbored a somatic mutation in BRAF (p.Val600Glu), which is usually associated with somatic MLH1 promoter methylation and the sporadic CRC pathway [13]. This evidence concerns the gene MLH1 and colorectal carcinoma.